Old Web
English
Sign In
Acemap
>
authorDetail
>
Joy Jiang
Joy Jiang
BioMarin Pharmaceutical
Gastroenterology
Biology
Pegvaliase
Adverse effect
Population
3
Papers
87
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
2018
Molecular Genetics and Metabolism
Janet A. Thomas
Harvey L. Levy
Stephen Amato
Jerry Vockley
Roberto T. Zori
David Dimmock
Cary O. Harding
Deborah A. Bilder
Haoling H. Weng
Joy Olbertz
Markus Merilainen
Joy Jiang
Kevin Larimore
Soumi Gupta
Zhonghua Gu
Hope Northrup
Prism Investigators
Show All
Source
Cite
Save
Citations (67)
Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: Combined phase 2 outcomes through PAL-003 extension study
2018
Orphanet Journal of Rare Diseases
Nicola Longo
Roberto T. Zori
Melissa Wasserstein
Jerry Vockley
Barbara K. Burton
Celeste Decker
Mingjin Li
Kelly Lau
Joy Jiang
Kevin Larimore
Janet A. Thomas
Show All
Source
Cite
Save
Citations (17)
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial
2018
Molecular Genetics and Metabolism
Cary O. Harding
R. Stephen Amato
Mary Stuy
Nicola Longo
Barbara K. Burton
John Posner
Haoling H. Weng
Markus Meriläinen
Zhonghua Gu
Joy Jiang
Jerry Vockley
Show All
Source
Cite
Save
Citations (3)
1